These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2508581)

  • 1. [Spontaneous endogenous LH increase in the stimulated cycle].
    Alexander H; Birkhäuser M; Zimmermann G; Huber P; Pavic N; Lehmann M; Baier D; Weber W; Haake KW
    Arch Gynecol Obstet; 1989; 245(1-4):994-9. PubMed ID: 2508581
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
    Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
    Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
    Polson DW; Kiddy DS; Mason HD; Franks S
    Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates - a randomized trial.
    Shahin AY; Mohammed SA
    Gynecol Endocrinol; 2014 Jul; 30(7):505-10. PubMed ID: 24592984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
    Seibel MM; Kamrava MM; McArdle C; Taymor ML
    Int J Fertil; 1984; 29(1):39-43. PubMed ID: 6146583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalmic-pituitary relationships in the polycystic ovary syndrome serum gonadotrophin levels following injection of oestradiol benzoate.
    Shaw RW; Duignan NM; Butt WR; Edwards RL; London DR
    Br J Obstet Gynaecol; 1975 Dec; 82(12):952-7. PubMed ID: 1106757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.
    Filicori M
    Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
    Uemura T; Yoshimura Y; Ishikawa M; Asukai K; Minaguchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):923-6. PubMed ID: 2507714
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM; Schoemaker HC; Drexhage HA; Schoemaker J
    Hum Reprod; 1993 Jun; 8(6):813-21. PubMed ID: 8345068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contributions to the recruitment of follicular development following ovarian wedge resection in polycystic ovary syndrome.
    Araki S; Chikazawa K; Akabori A; Ijima K; Tamada T
    Endocrinol Jpn; 1982 Feb; 29(1):57-68. PubMed ID: 6809453
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulsatile luteinizing hormone secretion in women with polycystic ovary syndrome under clomiphene citrate. Differences between responders and nonresponders.
    Sir-Petermann T; Alba F; Cohen P; Pacheco J; Devoto L; Rossmanith W
    Exp Clin Endocrinol; 1990 Sep; 96(1):45-51. PubMed ID: 2126241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
    Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
    Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.